The minimal residual disease (MRD) testing market continues to gain significant traction due to rising prevalence of chronic diseases, such as cancer and blood disorders. MRD testing allows clinicians to detect small number of malignant cells persisting post-treatment and aids in monitoring treatment response and prognosis. Growing demand for personalized medicine has prompted healthcare...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian